September 6, 2022
University of Cincinnati and Cincinnati Children's Hospital Medical Center researchers published new findings on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments in the journal PLOS ONE.
September 7, 2022
University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
September 7, 2022
GEN News highlighted recent University of Cincinnati and Cincinnati Children's Hospital Medical Center research on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments.
September 8, 2022
Radio show and podcast Sunday Morning Magazine featured the Klaserner family of parents John and Lorrie, UC pharmacy alumni, and children Adam and Ally, current students at UC's James L. Winkle College of Pharmacy.
September 9, 2022
University of Cincinnati stroke expert Pooja Khatri, MD, was featured in a WESA article providing insights on stroke recovery in light of Pennsylvania Senate candidate John Fetterman campaigning while recovering from a stroke.
September 12, 2022
The University of Cincinnati's Thomas Herzog, MD, was featured on 55KRC radio's Simply Medicine program to discuss a recent study that found that metastatic, or advance stage, cervical cancer cases are increasing in the United States.
September 15, 2022
The University of Cincinnati Gardner Neuroscience Institute is transforming into a Learning Health System, a data-driven, patient-centered approach with the goal of measurably improving outcomes for patients with neurological disorders.
September 15, 2022
HealthDay highlighted recent University of Cincinnati research that found administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
September 16, 2022
WLWT and Yahoo News highlighted work being done by University of Cincinnati Cancer Center researchers to advance cancer care through new immunotherapy and cellular therapy treatments.
September 19, 2022
Abhinav Sidana, MD, joined WVXU's Cincinnati Edition to discuss high-intensity focused ultrasound, a new treatment option for patients with prostate cancer.